Crinetics Pharmaceuticals, Inc. (CRNX)
33.67
-2.64
(-7.27%)
USD |
NASDAQ |
Mar 27, 16:00
33.67
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Liabilities (Quarterly) : 143.41M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 12.33M |
| Nektar Therapeutics | 190.57M |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Axsome Therapeutics, Inc. | 601.51M |
| Gossamer Bio, Inc. | 295.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.135B |
| Shareholders Equity (Quarterly) | 992.08M |
| Debt to Equity Ratio | 0.0489 |
| Current Ratio | 12.32 |
| Net Debt Paydown Yield | 0.02% |